The Diabetes Research Institute (DRI) is an innovator in many fields of diabetes research, but one of its primary strengths lies in islet cell transplantation, a cellular therapy that restores insulin production to normalize blood sugar control.
The technology that allows healthy islets to be separated and harvested from a donor pancreas was developed by Dr. Camillo Ricordi, DRI’s scientific director.
This system, together with the steadily improving methods to prevent cell rejection, has clearly shown the ability to reverse diabetes.
The DRI has already demonstrated that transplanted islets can function for more than 12 years. Much of its research is now aimed at increasing the supply of islet cells available for transplantation, as well as eliminating the need for anti-rejection drugs.
With an unwavering commitment to cure those now living with diabetes, along with its unique spirit of collaboration and its fast track approach to research, the DRI truly offers the best hope for a cure for those currently living with this disease.
>>Bench to Bedside
>>Integrated Research Approach
>>Global Collaboration
>>On the Fast Track